Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial
Status:
Terminated
Trial end date:
2019-06-26
Target enrollment:
Participant gender:
Summary
The effect of an intravenous bisphosphonate (zoledronic acid) on healing and symptoms of
stress fractures that do not respond to conservative/conventional treatment within 6 months,
will be investigated.